LHON: Mitochondrial mutations and more

Current Genomics

Volumn 12, Issue 1, 2011, Pages 44-54

  Kirches, E ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

ATP; Cybrid; LHON; mtDNA; OXPHOS; PTP; ROS

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINO ACID; CALCIUM; GLUTAMIC ACID; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

APOPTOSIS; ARTICLE; BIOENERGY; CELL DEATH; CYBRID; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE MUTATION; HUMAN; HYBRID CELL; LEBER HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL GENOME; MITOCHONDRIAL PERMEABILITY; NONHUMAN; OSTEOSARCOMA CELL; OXIDATIVE STRESS; PHENOTYPIC VARIATION; RETINA GANGLION CELL;

EID: 79951701975     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920211794520150     Document Type: Article

References (91)

1. von Graefe, A. Ein ungewoehnlicher Fall von hereditaererAmaurose. Arch. Ophthalmol., 1858, 4, 266-268.
2. Leber, T. Ueber hereditaere und congenital angelegte Sehnervenleiden. Arch. Ophthalmol., 1871, 17, 249-291.
3. Erickson, R.P. Leber's optic atrophy, a possible example of maternalinheritance. Am. J. Hum. Genet., 1972, 24, 348-349.
4. Wallace, D.C.; Singh, G.; Lott, M.T.; Hodge, J.A.; Schurr, T.G.; Lezza, A.M.; Elsas, L.J.; Nikoskelainen, E.K. Mitochondrial DNAmutation associated with Leber's hereditary optic neuropathy. Science, 1988, 242, 1427-1430.
5. Huoponen, K.; Vilkki, J.; Aula, P.; Nikoskelainen, E.K.; Savontaus, M.L. A new mtDNA mutation associateed with Leber hereditaryoptic neuroretinopathy. Am. J. Hum. Genet., 1991, 48, 1147-1153.
6. Johns, D.R.; Neufeld, M.J.; Park, R.D. An ND-6 mitochondrialDNA mutation associated with Leber hereditary optic neuropathy. Biochem. Biophys. Res. Commun., 1992, 187, 1551-1557.
7. Harding, A.E.; Sweeney, M.G.; Miller, D.H.; Mumford, C.J.; Kellar-Wood, H.; Menard, D.; McDonald, W.I.; Compston, D.A. Occurrenceof a multiple sclerosis-like illness in women who have aLeber's hereditary optic neuropathy mitochondrial DNA mutation. Brain, 1992, 115, 979-989.
8. Jun, A.S.; Brown, M.D.; Wallace, D.C. A mitochondrial DNAmutation at nucleotide pair 14459 of the NADH dehydrogenasesubunit 6 gene associated with maternally inherited Leber hereditaryoptic neuropathy and dystonia. Proc. Natl. Acad. Sci. USA, 1994, 91, 6206-6210.
9. Shoffner, J.M.; Brown, M.D.; Stugard, C.; Jun, A.S.; Pollock, S.; Haas, R.H.; Kaufman, A.; Koontz, D.; Kim, Y.; Graham, J.R. Leber'shereditary optic neuropathy plus dystonia is caused by a mitochondrialDNA point mutation. Ann. Neurol., 1995, 38, 163-169.
10. De Vries, D.D.; Went, L.N.; Bruyn, G.W.; Scholte, H.R.; Hofstra, R.M.; Bolhuis, P.A.; van Oost, B.A. Genetic and biochemical impairmentof mitochondrial complex I activity in a family with Leberhereditary optic neuropathy and hereditary spastic dystonia. Am. J. Hum. Genet., 1996, 58, 703-711.
11. Murakami, T.; Mita, S.; Tokunaga, M.; Maeda, H.; Ueyama, H.; Kumamoto, T.; Uchino, M.; Ando, M. Hereditary cerebellar ataxiawith Leber's hereditary optic neuropathy mitochondrial DNA11778 mutation. J. Neurol. Sci., 1996, 142, 111-113.
12. Nikoskelainen, E.K.; Marttila, R.J.; Huoponen, K.; Juvonenm V.; Lamminen, T.; Sonninen, P.; Savontaus, M.L. Leber's "plus": neurologicalabnormalities in patients with Leber's hereditary opticneuropathy. J. Neurol. Neurosurg. Psychiatry, 1995, 59, 160-164.
13. Vergani, L.; Martinuzzi, A.; Carelli, V.; Cortelli, P.; Montagna, P.; Schievano, G.; Carrozzo, R.; Angelini, C.; Lugaresi, E. MtDNAmutations associated with Leber's hereditary optic neuropathy: studieson cytoplasmic hybrid (cybrid) cells. Biochem. Biophys. Res. Commun., 1995, 210, 880-888.
14. Man, P.Y.; Turnbull, D.M.; Chinnery, P.F. Leber hereditary opticneuropathy. J. Med. Genet., 2002, 39, 162-169.
15. Yen, M.Y.; Wang, A.G.; Wei, Y.H. Leber's hereditary optic neuropathy:a multifactorial disease. Progr. Retin. Eye Res., 2006, 25, 381-396.
16. Majander, A.; Huoponen, K.; Savontaus, M.L.; Nikoskelainenm E.; Wikstrom, M. Electron transfer properties of NADH:ubiquinonereductase in the ND1/3460 and the ND4/11778 mutations of theLeber hereditary optic neuroretinopathy (LHON). FEBS Lett., 1991, 292, 289-292.
17. Howell, N.; Bindoff, L.A.; McCullough, D.A.; Kubacka, I.; Poulton, J.; Mackey, D.; Taylor, L.; Turnbull, D.M. Leber hereditaryoptic neuropathy: identification of the same mitochondrial ND1mutation in six pedigrees. Am. J. Hum. Genet., 1991, 49, 939-950.
18. Smith, P.R.; Cooper, J.M.; Govan, G.G.; Harding, A.E.; Schapira, A.H. Platelet mitochondrial function in Leber's hereditary opticneuropathy. J. Neurol. Sci., 1994, 122, 80-83.
19. Carelli, V.; Ghelli, A.; Ratta, M.; Bacchilega, E.; Sangiorgi, S.; Mancini, R.; Leuzzi, V.; Cortelli, P.; Montagna, P.; Lugaresi, E.; Degli Esposti, M. Leber's hereditary optic neuropathy: biochemicaleffect of 11778/ND4 and 3460/ND1 mutations and correlation withthe mitochondrial genotype. Neurology, 1997, 48, 1623-1632.
20. Brown, M.D.; Trounce, I.A.; Jun, A.S.; Allen, J.C.; Wallace, D.C. Functional analysis of lymphoblast and cybrid mitochondria containingthe 3460, 11778, or 14484 Leber's hereditary optic neuropathymitochondrial DNA mutation. J. Biol. Chem., 2000, 275, 39831-39836.
21. Carelli, V.; Ghelli, A.; Bucchi, L.; Montagna, P.; De Negri, A.; Leuzzi, V.; Carducci, C.; Lenaz, G.; Lugaresi, E.; Degli Esposti, M. Biochemical features of mtDNA 14484 (ND6/M64V) point mutationassociated with Leber's hereditary optic neuropathy. Ann. Neurol., 1999, 45, 320-328.
22. Hofhaus, G.; Johns, D.R.; Hurko, O.; Attardi, G.; Chomyn, A. Respiration and growth defects in transmitochondrial cell lines carryingthe 11778 mutation associated with Leber's hereditary opticneuropathy. J. Biol. Chem., 1996, 271, 13155-13161.
23. King, M.P.; Attardi, G. Human cells lacking mtDNA: repopulationwith exogenous mitochondria by complementation. Science, 1989, 246, 500-503.
24. Gregoire, M.; Morais, R.; Quilliam, M.A.; Gravel, D. On auxotrophyfor pyrimidines of respiration-deficient chick embryo cells. Eur. J. Biochem., 1984, 142, 49-55.
25. Danielson, S.R.; Wong, A.; Carelli, V.; Martinuzzi, A.; Schapira, A.H.; Cortopassi, G.A. Cells bearing mutations causing Leber's hereditaryoptic neuropathy are sensitized to Fas-Induced apoptosis. J. Biol. Chem., 2002, 277, 5810-5815.
26. Ghelli, A.; Zanna, C.; Porcelli, A.M.; Schapira, A.H.; Martinuzzi, A.; Carelli, V.; Rugolo, M. Leber's hereditary optic neuropathy(LHON) pathogenic mutations induce mitochondrial-dependentapoptotic death in transmitochondrial cells incubated with galactosemedium. J. Biol. Chem., 2003, 278, 4145-4150.
27. Zanna, C.; Ghelli, A.; Porcelli, A.M.; Martinuzzi, A.; Carelli, V.; Rugolo, M. Caspase-independent death of Leber's hereditary opticneuropathy cybrids is driven by energetic failure and mediated byAIF and Endonuclease G. Apoptosis, 2005, 10, 997-1007.
28. Baracca, A.; Solaini, G.; Sgarbi, G.; Lenaz, G.; Baruzzi, A.; Schapira, A.H.; Martinuzzi, A.; Carelli, V. Severe impairment ofcomplex I-driven adenosine triphosphate synthesis in leber hereditaryoptic neuropathy cybrids. Arch. Neurol., 2005, 62, 730-736.
29. Wong, A.; Cavelier, L.; Collins-Schramm, H.E.; Seldin, M.F.; McGrogan, M.; Savontaus, M.L.; Cortopassi, G.A. Differentiationspecificeffects of LHON mutations introduced into neuronal NT2cells. Hum. Mol. Genet., 2002, 11, 431-438.
30. Haroon, M.F.; Fatima, A.; Scholer, S.; Gieseler, A.; Horn, T.F.; Kirches, E.; Wolf, G.; Kreutzmann, P. Minocycline, a possible neuroprotectiveagent in Leber's hereditary optic neuropathy (LHON):studies of cybrid cells bearing 11, 778 mutation. Neurobiol. Dis., 2007, 28, 237-250.
31. Schoeler, S.; Winkler-Stuck, K.; Szibor, R.; Haroon, M.F.; Gellerich, F.N.; Chamaon, K.; Mawrin, C.; Kirches, E. Glutathionedepletion in antioxidant defense of differentiated NT2-LHON cybrids. Neurobiol. Dis., 2007, 25, 536-544.
32. Howell, N. Leber hereditary optic neuropathy: how do mitochondrialDNA mutations cause degeneration of the optic nerve? J. Bioenerg. Biomembr., 1997, 29, 165-173.
33. Howell, N. Human mitochondrial diseases: answering questionsand questioning answers. Int. Rev. Cytol., 1999, 186, 49-116.
34. Fontaine, E.; Eriksson, O.; Ichas, F.; Bernardi, P. Regulation of thepermeability transition pore in skeletal muscle mitochondria. Modulation By electron flow through the respiratory chain complexi. J. Biol. Chem., 1998, 273, 12662-12668.
35. Li, G.Y.; Fan, B.; Su, G.F. Acute energy reduction inducescaspase-dependent apoptosis and activates p53 in retinal ganglioncells (RGC-5). Exp. Eye Res., 2009, 89, 581-589.
36. Robinson, B.H.; Petrova-Benedict, R.; Buncic, J.R.; Wallace, D.C. Nonviability of cells with oxidative defects in galactose medium: ascreening test for affected patient fibroblasts. Biochemi. Med. Metab. Biol., 1992, 48, 122-126.
37. Zanna, C.; Ghelli, A.; Porcelli, A.M.; Carelli, V.; Martinuzzi, A.; Rugolo, M. Apoptotic cell death of cybrid cells bearing Leber's hereditaryoptic neuropathy mutations is caspase independent. Ann.N.Y. Acad. Sci., 2003, 1010, 213-217.
38. Wong, A.; Cortopassi, G. mtDNA mutations confer cellular sensitivityto oxidant stress that is partially rescued by calcium depletionand cyclosporin A. Biochem. Biophys. Res. Commun., 1997, 239, 139-145.
39. Porcelli, A.M.; Angelin, A.; Ghelli, A.; Mariani, E.; Martinuzzi, A.; Carelli, V.; Petronilli, V.; Bernardi, P.; Rugolo, M. Respiratorycomplex I dysfunction due to mitochondrial DNA mutations shiftsthe voltage threshold for opening of the permeability transitionpore toward resting levels. J. Biol. Chem., 2009, 284, 2045-2052.
40. Floreani, M.; Napoli, E.; Martinuzzi, A.; Pantano, G.; De Riva, V.; Trevisan, R.; Bisetto, E.; Valente, L.; Carelli, V.; Dabbeni-Sala, F. Antioxidant defences in cybrids harboring mtDNA mutations associatedwith Leber's hereditary optic neuropathy. FEBS J., 2005, 272, 1124-1135.
41. Ghelli, A.; Porcelli, A.M.; Zanna, C.; Martinuzzi, A.; Carelli, V.; Rugolo, M. Protection against oxidant-induced apoptosis by exogenousglutathione in Leber hereditary optic neuropathy cybrids. Invest. Ophthalmol. Vis. Sci., 2008, 49, 671-676.
42. Qi, X.; Sun, L.; Hauswirth, W.W.; Lewin, A.S.; Guy, J. Use ofmitochondrial antioxidant defenses for rescue of cells with a Leberhereditary optic neuropathy-causing mutation. Arch. Ophthalmol., 2007, 125, 268-272.
43. Li, G.Y.; Osborne, N.N. Oxidative-induced apoptosis to an immortalizedganglion cell line is caspase independent but involves theactivation of poly(ADP-ribose)polymerase and apoptosis-inducingfactor. Brain Res., 2008, 1188, 35-43.
44. Danielson, S.R.; Carelli, V.; Tan, G.; Martinuzzi, A.; Schapira, A.H.; Savontaus, M.L.; Cortopassi, G.A. Isolation of transcriptomalchanges attributable to LHON mutations and the cybridizationprocess. Brain, 2005, 128, 1026-1037.
45. Curcio, C.A.; Allen, K.A. Topography of ganglion cells in humanretina. J. Comp. Neurol., 1990, 300, 5-25.
46. Waxman, S.G. Prerequisites for conduction in demyelinated fibers. Neurology, 1978, 28, 27-33.
47. Andrews, R.M.; Griffiths, P.G.; Johnson, M.A.; Turnbull, D.M. Histochemical localisation of mitochondrial enzyme activity inhuman optic nerve and retina. Br.J. Ophthalmol., 1999, 83, 231-235.
48. Barron, M.J.; Griffiths, P.; Turnbull, D.M.; Bates, D.; Nichols, P. The distributions of mitochondria and sodium channels reflect thespecific energy requirements and conduction properties of the humanoptic nerve head. Br. J. Ophthalmol., 2004, 88, 286-290.
49. Morgan, J.E. Circulation and axonal transport in the optic nerve. Eye, 2004, 18, 1089-1095.
50. Barboni, P.; Carbonelli, M.; Savini, G.; Ramos, V.; Carta, A.; Berezovsky, A.; Salomao, S.R.; Carelli, V.; Sadun, A.A. Naturalhistory of Leber's hereditary optic neuropathy: longitudinal analysisof the retinal nerve fiber layer by optical coherence tomography. Ophthalmology, 2010, 117, 623-627.
51. Hollander H, Makarov F, Stefani FH, Stone J Evidence of constrictionof optic nerve axons at the lamina cribrosa in the normotensiveeye in humans and other mammals. Ophthalmic Res., 1995, 27, 296-309.
52. Minckler DS, McLean IW, Tso MO Distribution of axonal andglial elements in the rhesus optic nerve head studied by electronmicroscopy. Am. J. Ophthalmol., 1976, 82, 179-187.
53. Bristow, E.A.; Griffiths, P.G.; Andrews, R.M.; Johnson, M.A.; Turnbull, D.M. The distribution of mitochondrial activity in relationto optic nerve structure. Arch. Opthalmol., 2002, 120, 791-796.
54. Yu Wai Man, C.Y.; Chinnery, P.F.; Griffiths, P.G. Optic neuropathies--importance of spatial distribution of mitochondria as well asfunction. Med. Hypotheses, 2005, 65, 1038-1042.
55. Burde, R.M. Optic disk risk factors for nonarteritic anteriorischemic optic neuropathy. Am. J. Ophthalmol., 1993, 116, 759-764.
56. Liu, X.; Weaver, D.; Shirihai, O.; Hajnoczky, G. Mitochondrial'kiss-and-run': interplay between mitochondrial motility and fusionfissiondynamics. EMBO J., 2009, 28, 3074-3089.
57. Song, Z.; Chen, H.; Fiket, M.; Alexander, C.; Chan, D.C. OPA1processing controls mitochondrial fusion and is regulated bymRNA splicing, membrane potential, and Yme1L. J. Cell Biol., 2007, 178, 749-755.
58. Griparic, L.; van der Wel, N.N.; Orozco, I.J.; Peters, P.J.; van derBliek, A.M. Loss of the intermembrane space protein Mgm1/OPA1induces swelling and localized constrictions along the lengths ofmitochondria. J. Biol. Chem., 2004, 279, 18792-18798.
59. Olichon, A.; Baricault, L.; Gas, N.; Guillou, E.; Valette, A.; Belenguer, P.; Lenaers, G. Loss of OPA1 perturbates the mitochondrialinner membrane structure and integrity, leading to cytochrome c releaseand apoptosis. J. Biol. Chem., 2003, 278, 7743-7746.
60. Olichon, A.; Landes, T.; Arnaune-Pelloquin, L.; Emorine, L.J.; Mils, V.; Guichet, A.; Delettre, C.; Hamel, C.; Amati-Bonneau, P.; Bonneau, D.; Reynier, P.; Lenaers, G.; Belenguer, P. Effects ofOPA1 mutations on mitochondrial morphology and apoptosis:relevance to ADOA pathogenesis. J. Cell. Physiol., 2007, 211, 423-430.
61. Smirnova, E.; Shurland, D.L.; Ryazantsev, S.N.; van der Bliek, A.M. A human dynamin-related protein controls the distribution ofmitochondria. J. Cell Biol., 1998, 143, 351-358.
62. Ferreirinha, F.; Quattrini, A.; Pirozzi, M.; Valsecchi, V.; Dina, G.; Broccoli, V.; Auricchio, A.; Piemonte, F.; Tozzi, G.; Gaeta, L.; Casari, G.; Ballabio, A.; Rugarli, E.I. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria andimpairment of axonal transport. J. Clin. Invest., 2004, 113, 231-242.
63. Carelli, V.; Ross-Cisneros, F.N.; Sadun, A.A. Optic nerve degenerationand mitochondrial dysfunction: genetic and acquired opticneuropathies. Neurochem. Int., 2002, 40, 573-584.
64. Sadun, A.; Kashima, Y.; Wurdeman, A.E.; Dao, J.; Heller, K.B.; Sherman, J. Morphological findings in the visual system in a caseof Leber's hereditary optic neuropathy. Clin. Neurosci., 1994, 2, 165-172.
65. Sadun, A.A.; Carelli, V. Mitochondrial function and dysfunctionwithin the optic nerve. Arch. Ophthalmol., 2003, 121, 1342-1343.
66. Rauen, T.; Rothstein, J.D.; Wassle, H. Differential expression ofthree glutamate transporter subtypes in the rat retina. Cell TissueRes., 1996, 286, 325-336.
67. Vorwerk, C.K.; Lipton, S.A.; Zurakowski, D.; Hyman, B.T.; Sabel, B.A.; Dreyer, E.B. Chronic low-dose glutamate is toxic to retinalganglion cells. Toxicity blocked by memantine. Invest. Ophthalmol. Vis. Sci., 1996, 37, 1618-1624.
68. Harada, T.; Harada, C.; Watanabe, M.; Inoue, Y.; Sakagawa, T.; Nakayama, N.; Sasaki, S.; Okuyama, S.; Watase, K.; Wada, K.; Tanaka, K. Functions of the two glutamate transporters GLASTand GLT-1 in the retina. Proc. Natl. Acad. Sci. USA, 1998, 95, 4663-4666.
69. Beretta, S.; Mattavelli, L.; Sala, G.; Tremolizzo, L.; Schapira, A.H.; Martinuzzi, A.; Carelli, V.; Ferrarese, C. Leber hereditary opticneuropathy mtDNA mutations disrupt glutamate transport in cybridcell lines. Brain, 2004, 127, 2183-2192.
70. Trotti, D.; Danbolt, N.C.; Volterra, A. Glutamate transporters areoxidant-vulnerable: a molecular link between oxidative and excitotoxicneurodegeneration? Trends Pharmacol. Sci., 1998, 19, 328-334.
71. Sala, G.; Trombin, F.; Beretta, S.; Tremolizzo, L.; Presutto, P.; Montopoli, M.; Fantin, M.; Martinuzzi, A.; Carelli, V.; Ferrarese, C. Antioxidants partially restore glutamate transport defect in leberhereditary optic neuropathy cybrids. J. Neurosci. Res., 2008, 86, 3331-3337.
72. Beretta, S.; Wood, J.P.; Derham, B.; Sala, G.; Tremolizzo, L.; Ferrarese, C.; Osborne, N.N. Partial mitochondrial complex I inhibitioninduces oxidative damage and perturbs glutamate transportin primary retinal cultures. Relevance to Leber Hereditary OpticNeuropathy (LHON). Neurobiol. Dis., 2006, 24, 308-317.
73. Sarthy, V.P.; Pignataro, L.; Pannicke, T.; Weick, M.; Reichenbach, A.; Harada, T.; Tanaka, K.; Marc, R. Glutamate transport by retinalMuller cells in glutamate/aspartate transporter-knockout mice. Glia, 2005, 49, 184-196.
74. Barbiroli, B.; Montagna, P.; Cortelli, P.; Iotti, S.; Lodi, R.; Barboni, P.; Monari, L.; Lugaresi, E.; Frassineti, C.; Zaniol, P. Defectivebrain and muscle energy metabolism shown by in vivo 31P magneticresonance spectroscopy in nonaffected carriers of 11778mtDNA mutation. Neurology, 1995, 45, 1364-1369.
75. Cortelli, P.; Montagna, P.; Pierangeli, G.; Lodi, R.; Barboni, P.; Liguori, R.; Carelli, V.; Iotti, S.; Zaniol, P.; Lugaresi, E.; Barbiroli, B. Clinical and brain bioenergetics improvement with idebenone ina patient with Leber's hereditary optic neuropathy: a clinical and31P-MRS study. J. Neurol. Sci., 1997, 148, 25-31.
76. Cortelli, P.; Montagna, P.; Avoni, P.; Sangiorgi, S.; Bresolin, N.; Moggio, M.; Zaniol, P.; Mantovani, V.; Barboni, P.; Barbiroli, B. Leber's hereditary optic neuropathy: genetic, biochemical, and phosphorusmagnetic resonance spectroscopy study in an Italianfamily. Neurology, 1991, 41, 1211-1215.
77. Lodi, R.; Carelli, V.; Cortelli, P.; Iotti, S.; Valentino, M.L.; Barboni, P.; Pallotti, F.; Montagna, P.; Barbiroli, B. Phosphorus MRspectroscopy shows a tissue specific in vivo distribution of biochemicalexpression of the G3460A mutation in Leber's hereditary opticneuropathy. J. Neurol. Neurosurg. Psychiatry, 2002, 72, 805-807.
78. Qi, X.; Sun, L.; Lewin, A.S.; Hauswirth, W.W.; Guy, J. The mutanthuman ND4 subunit of complex I induces optic neuropathy in themouse. Invest. Ophthalmol. Vis. Sci., 2007, 48, 1-10.
79. Ellouze, S.; Augustin, S.; Bouaita, A.; Bonnet, C.; Simonutti, M.; Forster, V.; Picaud, S.; Sahel, J.A.; Corral-Debrinski, M. Optimizedallotopic expression of the human mitochondrial ND4 preventsblindness in a rat model of mitochondrial dysfunction. Am. J. Hum. Genet., 2008, 83, 373-387.
80. Brown, M.D.; Sun, F.; Wallace, D.C. Clustering of CaucasianLeber hereditary optic neuropathy patients containing the 11778 or14484 mutations on an mtDNA lineage. Am. J. Hum. Genet., 1997, 60, 381-387.
81. Hudson, G.; Carelli, V.; Spruijt, L.; Gerards, M.; Mowbray, C.; Achilli, A.; Pyle, A.; Elson, J.; Howell, N.; La Morgia, C.; Valentino, M.L.; Huoponen, K.; Savontaus, M.L.; Nikoskelainen, E.; Sadun, A.A.; Salomao, S.R.; Belfort, R.; Griffiths, P.; Man, P.Y.; de Coo, R.F.; Horvath, R.; Zeviani, M.; Smeets, H.J.; Torroni, A.; Chinnery, P.F. Clinical expression of Leber hereditary optic neuropathyis affected by the mitochondrial DNA-haplogroup background. Am. J. Hum. Genet., 2007, 81, 228-233.
82. Vilkki, J.; Ott, J.; Savontaus, M.L.; Aula, P.; Nikoskelainen, E.K. Optic atrophy in Leber hereditary optic neuroretinopathy is probablydetermined by an X-chromosomal gene closely linked toDXS7. Am. J. Hum. Genet., 1991, 48, 486-491.
83. Hudson, G.; Keers, S.; Yu Wai Man, P.; Griffiths, P.; Huoponen, K.; Savontaus, M.L.; Nikoskelainen, E.; Zeviani, M.; Carrara, F.; Horvath, R.; Karcagi, V.; Spruijt, L.; de Coo, I.F.; Smeets, H.J.; Chinnery, P.F. Identification of an X-chromosomal locus andhaplotype modulating the phenotype of a mitochondrial DNA disorder. Am. J. Hum. Genet., 2005, 77, 1086-1091.
84. Shankar, S.P.; Fingert, J.H.; Carelli, V.; Valentino, M.L.; King, T.M.; Daiger, S.P.; Salomao, S.R.; Berezovsky, A.; Belfort, R.; Braun, T.A.; Sheffield, V.C.; Sadun, A.A.; Stone, E.M. Evidencefor a novel x-linked modifier locus for leber hereditary optic neuropathy. Ophthalmic Genet., 2008, 29, 17-24.
85. Ji, Y.; Jia, X.; Li, S.; Xiao, X.; Guo, X.; Zhang, Q. Evaluation ofthe X-linked modifier loci for Leber hereditary optic neuropathywith the G11778A mutation in Chinese. Mol. Vis., 2010, 16, 416-424.
86. Phasukkijwatana, N.; Kunhapan, B.; Stankovich, J.; Chuenkongkaew, W.L.; Thomson, R.; Thornton, T.; Bahlo, M.; Mushiroda, T.; Nakamura, Y.; Mahasirimongkol, S.; Tun, A.W.; Srisawat, C.; Limwongse, C.; Peerapittayamongkol, C.; Sura, T.; Suthammarak, W.; Lertrit, P. Genome-wide linkage scan and association study ofPARL to the expression of LHON families in Thailand. Hum. Genet., 2010, 128, 39-49.
87. Zhang, A.M.; Jia, X.; Zhang, Q.; Yao, Y.G. No association betweenthe SNPs (rs3749446 and rs1402000) in the PARL gene andLHON in Chinese patients with m.11778G>A. Hum. Genet., 2010, 128, 465-468.
88. Johns, D.R.; Sadun, A.A. Cuban epidemic optic neuropathy. MitochondrialDNA analysis. J. Neuroophthalmol., 1994, 14, 130-134.
89. Kirkman, M.A.; Yu-Wai-Man, P.; Korsten, A.; Leonhardt, M.; Dimitriadis, K.; De Coo, I.F.; Klopstock, T.; Chinnery, P.F. Geneenvironmentinteractions in Leber hereditary optic neuropathy. Brain, 2009, 132, 2317-2326.
90. Guy, J.; Qi, X.; Pallotti, F.; Schon, E.A.; Manfredi, G.; Carelli, V.; Martinuzzi, A.; Hauswirth, W.W.; Lewin, A.S. Rescue of a mitochondrialdeficiency causing Leber Hereditary Optic Neuropathy. Ann. Neurol., 2002, 52, 534-542.
91. Lam, B.L.; Feuer, W.J.; Abukhalil, F.; Porciatti, V.; Hauswirth, W.W.; Guy, J. Leber hereditary optic neuropathy gene therapyclinical trial recruitment: year 1. Arch. Ophthalmol., 2010, 128, 1129-1135.